Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Bovie Medical Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 26.95M 24.23M 25.41M 27.67M 23.66M
Cost of Goods Sold (COGS) incl. D&A 15.1M 14.24M 17.79M 19.52M 17.79M
COGS excluding D&A 14.05M 13.24M 16.87M 18.66M 16.96M
Depreciation & Amortization Expense 1.05M 1.01M 925,000 857,000 827,000
Depreciation 776,825 734,000 753,000 742,000 739,000
Amortization of Intangibles 272,808 272,000 172,000 115,000 88,000
Gross Income 11.85M 9.99M 7.62M 8.16M 5.88M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 9.48M 11.45M 5.54M 7.11M 7.9M
Research & Development 2.08M 1.85M 1.2M 1.33M 1.26M
Other SG&A 7.39M 9.6M 4.35M 5.78M 6.64M
Other Operating Expense 1.4M 0 1.25M 0 0
Unusual Expense 265,000 773,000 554,000 (20,000) 2.48M
EBIT after Unusual Expense (265,000) (773,000) (554,000) 20,000 (2.48M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 24,362 - - 7,000 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 76,370 223,000 237,000 239,000 1.44M
Gross Interest Expense 76,370 223,000 237,000 239,000 1.44M
Interest Capitalized 0 0 0 0 -
Pretax Income 662,841 (2.46M) 32,000 834,000 (5.95M)
Income Tax 67,319 (927,000) (77,000) 217,000 (1.61M)
Income Tax - Current Domestic - - - 0 0
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - 217,000 (1.61M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 595,522 (1.54M) 109,000 617,000 (4.34M)
Minority Interest Expense 0 0 0 0 0
Net Income 595,522 (1.54M) 109,000 617,000 (4.34M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 595,522 (1.54M) 109,000 617,000 (4.34M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 595,522 (1.54M) 109,000 617,000 (4.34M)
EPS (Basic) 0.04 (0.09) 0.01 0.04 (0.25)
Basic Shares Outstanding 16.9M 17.37M 17.6M 17.63M 17.67M
EPS (Diluted) 0.03 (0.09) 0.01 0.03 (0.25)
Diluted Shares Outstanding 17.84M 17.37M 17.67M 17.79M 17.67M
EBITDA 2.03M (460,000) 1.75M 1.9M (1.2M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.